Journal of International Obstetrics and Gynecology ›› 2022, Vol. 49 ›› Issue (6): 649-654.doi: 10.12280/gjfckx.20220244
• Obstetric Physiology & Obstetric Disease: Review • Previous Articles Next Articles
SONG Shuang, QIAO Chong
Received:
2022-04-05
Published:
2022-12-15
Online:
2023-01-11
SONG Shuang, QIAO Chong. [J]. Journal of International Obstetrics and Gynecology, 2022, 49(6): 649-654.
Add to citation manager EndNote|Ris|BibTeX
指标 | 2分 | 1分 | 0分 |
---|---|---|---|
胎儿水肿 | 无 | 心包积液或胸腹水 | 胎儿水肿 |
心/胸面积比 | 心胸面积比0.25~0.35 | >0.35~0.5 | <0.25或>0.5 |
心脏功能 | 瓣膜无返流 | 三尖瓣返流 | 二尖瓣返流 |
脐动脉血流频谱 | 正常 | 舒张期血流消失 | 舒张期血流反向 |
静脉导管频谱 | 正常 | a波反向 | a波消失 |
指标 | 2分 | 1分 | 0分 |
---|---|---|---|
胎儿水肿 | 无 | 心包积液或胸腹水 | 胎儿水肿 |
心/胸面积比 | 心胸面积比0.25~0.35 | >0.35~0.5 | <0.25或>0.5 |
心脏功能 | 瓣膜无返流 | 三尖瓣返流 | 二尖瓣返流 |
脐动脉血流频谱 | 正常 | 舒张期血流消失 | 舒张期血流反向 |
静脉导管频谱 | 正常 | a波反向 | a波消失 |
[1] |
Alsaied T, Baskar S, Fares M, et al. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis[J]. J Am Heart Assoc, 2017, 6(12):e007164. doi: 10.1161/JAHA.117.007164.
doi: 10.1161/JAHA.117.007164 |
[2] |
Yuan SM. Fetal Arrhythmias: Genetic Background and Clinical Implications[J]. Pediatr Cardiol, 2019, 40(2):247-256. doi: 10.1007/s00246-018-2008-3.
doi: 10.1007/s00246-018-2008-3 |
[3] |
Huhta JC. Fetal congestive heart failure[J]. Semin Fetal Neonatal Med, 2005, 10(6):542-552. doi:10.1016/j.siny.2005.08.005.
doi: 10.1016/j.siny.2005.08.005 |
[4] |
Miyoshi T, Hosoda H, Kurosaki KI, et al. Plasma natriuretic peptide levels reflect the status of the heart failure in fetuses with arrhythmia[J]. J Matern Fetal Neonatal Med, 2021, 34(12):1883-1889. doi: 10.1080/14767058.2019.1651271.
doi: 10.1080/14767058.2019.1651271 |
[5] |
张文, 朱琦, 陈娇, 等. 心血管整体评分在胎儿心律失常中的价值[J]. 中国临床医学影像杂志, 2019, 30(1):12-14,31. doi: 10.12117/jccmi.2019.01.004.
doi: 10.12117/jccmi.2019.01.004 |
[6] |
Carvalho JS. Fetal dysrhythmias[J]. Best Pract Res Clin Obstet Gynaecol, 2019, 58:28-41. doi: 10.1016/j.bpobgyn.2019.01.002.
doi: S1521-6934(18)30262-1 pmid: 30738635 |
[7] | Freeman RK, Garite TJ, Nageotte MP, et al. Fetal heart rate monitoring[M]. Fourth edition. Lippincott Williams & Wilkins, 2012. |
[8] |
Veduta A, Panaitescu AM, Ciobanu AM, et al. Treatment of Fetal Arrhythmias[J]. J Clin Med, 2021, 10(11):2510. doi: 10.3390/jcm10112510.
doi: 10.3390/jcm10112510 |
[9] |
Demirci O, Tosun Ö, Bolat G. Prenatal diagnosis and management of fetal supraventricular tachyarrhythmia and postnatal outcomes[J]. J Gynecol Obstet Hum Reprod, 2022, 51(3):102323. doi: 10.1016/j.jogoh.2022.102323.
doi: 10.1016/j.jogoh.2022.102323 |
[10] |
Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers[J]. J Am Coll Cardiol, 2020, 76(3):292-302. doi: 10.1016/j.jacc.2020.05.045.
doi: S0735-1097(20)35402-4 pmid: 32674792 |
[11] |
Strand S, Strasburger JF, Lutter WJ, et al. Repolarization Predictors of Fetal Long QT Syndrome[J]. Heart Rhythm O2, 2020, 1(3):200-205. doi: 10.1016/j.hroo.2020.05.003.
doi: 10.1016/j.hroo.2020.05.003 pmid: 33543149 |
[12] |
Sharp A, Patient C, Pickett J, et al. Pregnancy-related inappropriate sinus tachycardia: A cohort analysis of maternal and fetal outcomes[J]. Obstet Med, 2021, 14(4):230-234. doi: 10.1177/1753495X21990196.
doi: 10.1177/1753495X21990196 |
[13] |
Wacker-Gussmann A, Strasburger JF, Wakai RT. Contribution of Fetal Magnetocardiography to Diagnosis, Risk Assessment, and Treatment of Fetal Arrhythmia[J]. J Am Heart Assoc, 2022, 11(15):e025224. doi: 10.1161/JAHA.121.025224.
doi: 10.1161/JAHA.121.025224 |
[14] |
Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval[J]. Am J Cardiol, 2000, 86(2):236-239. doi: 10.1016/s0002-9149(00)00867-5.
doi: 10.1016/s0002-9149(00)00867-5 pmid: 10913494 |
[15] |
Hansahiranwadee W. Diagnosis and Management of Fetal Autoimmune Atrioventricular Block[J]. Int J Womens Health, 2020, 12:633-639. doi: 10.2147/IJWH.S257407.
doi: 10.2147/IJWH.S257407 pmid: 32884363 |
[16] |
Tugcu AU, Ince DA, Esin S, et al. Complete Fetal Atrioventricular Block Associated with Maternal Autoinflammatory Diseases: Case Report and Literature Review[J]. Acta Cardiol Sin, 2020, 36(1):72-75. doi: 10.6515/ACS.202001_36(1).20190711A.
doi: 10.6515/ACS.202001_36(1).20190711A pmid: 31903011 |
[17] |
Jaeggi ET, Silverman ED, Laskin C, et al. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses[J]. J Am Coll Cardiol, 2011, 57(13):1487-1492. doi: 10.1016/j.jacc.2010.12.014.
doi: 10.1016/j.jacc.2010.12.014 pmid: 21435519 |
[18] |
Kang SL, Howe D, Coleman M, et al. Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone[J] Cardiol Young, 2015, 25(3):447-453. doi: 10.1017/S104795111400002X.
doi: 10.1017/S104795111400002X |
[19] |
张慧婧, 杨慧霞. 胎儿心律失常的宫内治疗现状[J]. 中华围产医学杂志, 2021, 24(4):241-244. doi: 10.3760/cma.j.cn113903-20210315-00214.
doi: 10.3760/cma.j.cn113903-20210315-00214 |
[20] |
Miyoshi T, Maeno Y, Hamasaki T, et al. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial[J]. J Am Coll Cardiol, 2019, 74(7):874-885. doi: 10.1016/j.jacc.2019.06.024.
doi: 10.1016/j.jacc.2019.06.024 |
[21] |
Sridharan S, Sullivan I, Tomek V, et al. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols[J]. Heart Rhythm, 2016, 13(9):1913-1919. doi: 10.1016/j.hrthm.2016.03.023.
doi: 10.1016/j.hrthm.2016.03.023 pmid: 27554948 |
[22] |
Strizek B, Berg C, Gottschalk I, et al. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia[J]. Heart Rhythm, 2016, 13(6):1283-1288. doi: 10.1016/j.hrthm.2016.01.029.
doi: 10.1016/j.hrthm.2016.01.029 pmid: 26829115 |
[23] |
Ekiz A, Kaya B, Bornaun H, et al. Flecainide as first-line treatment for fetal supraventricular tachycardia[J]. J Matern Fetal Neonatal Med, 2018, 31(4):407-412. doi: 10.1080/14767058.2017.1286317.
doi: 10.1080/14767058.2017.1286317 pmid: 28114840 |
[24] |
Uzun O, Babaoglu K, Sinha A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment[J]. Cardiol Young, 2012, 22(4):372-380. doi: 10.1017/S1047951111001272.
doi: 10.1017/S1047951111001272 pmid: 22008551 |
[25] |
Ekman-Joelsson BM, Mellander M, Lagnefeldt L, et al. Foetal tachyarrhythmia treatment remains challenging even if the vast majority of cases have a favourable outcome[J]. Acta Paediatr, 2015, 104(11):1090-1097. doi:10.1111/apa.13111.
doi: 10.1111/apa.13111 |
[26] |
Zaidi SJ, Siddiqui S, Cuneo BF, et al. Prenatal diagnosis and management of junctional ectopic tachycardia[J]. HeartRhythm Case Rep, 2017, 3(11):503-508. doi: 10.1016/j.hrcr.2017.07.022.
doi: 10.1016/j.hrcr.2017.07.022 pmid: 29387539 |
[27] |
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus[J]. Circulation, 2012, 126(1):76-82. doi: 10.1161/CIRCULATIONAHA.111.089268.
doi: 10.1161/CIRCULATIONAHA.111.089268 pmid: 22626746 |
[28] |
Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review[J]. Scand J Immunol, 2010, 72(3):235-241. doi: 10.1111/j.1365-3083.2010.02440.x.
doi: 10.1111/j.1365-3083.2010.02440.x pmid: 20696021 |
[29] |
Ruffatti A, Cerutti A, Favaro M, et al. Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study[J]. Clin Exp Rheumatol, 2016, 34(4):706-713.
pmid: 27385463 |
[1] | CHEN Xiao-juan, ZHANG Yan-xin. A Case of Full-Term Delivery in A Pregnant Patient with Hemophilia A [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 158-160. |
[2] | ZHANG Hao-sheng, WEI Fang. Research Progress of Nectin-4 in Gynecologic Malignancies [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 165-168. |
[3] | CHEN Shu-wan, DENG Gao-pi, YUAN Shuo. A Case of Uterine Leiomyoma with Bizarre Nucleus [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 187-190. |
[4] | JIANG Ai-mei, ZHANG Xin-mei. Advances in the Treatment of Abdominal Wall Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 211-216. |
[5] | BAI Yao-jun, WANG Si-yao, LING Fei-fei, ZHANG Sen-huai, LI Hong-li, LIU Chang. Progress of Trop-2 and Targeted Trop-2 Antibody-Coupled Drugs in Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 1-7. |
[6] | HOU Chun-yan, DU Xiu-ping. Two Cases of Spontaneous Uterine Rupture in the Middle and Late Stages of Pregnancy [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 110-113. |
[7] | ZHONG Pei-qu, ZHAO Li-jian, ZOU Xin-xin. A Case of Rudimentary Horn Pregnancy Undergoing Expectant Treatment until the Third Trimester [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 114-116. |
[8] | PAN Qi, FENG Tong-fu, JIN Jing, WU Ying, DU Xin. Laparoscopic Resection of Giant Mature Retroperitoneal Teratoma in An Adult: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 28-31. |
[9] | JIA Yan-feng, WU Zhen-zhen, WANG Wei-hong, WANG Yue-yuan, LI Juan. A Case of Primary Ovarian Adenosquamous Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 32-36. |
[10] | SONG Li-fang, WU Zhen-zhen, MAO Bao-hong, ZHAO Xiao-li, LIU Qing. A Case of Isolated Lymph Node Metastasis from Ovarian Cancer to the Inguinal Region [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 37-41. |
[11] | SHI Bai-chao, WANG Yu, CHANG Hui, LU Feng-juan, GUAN Mu-xin, YU Jian-nan, WU Xiao-ke. Mechanism of Traditional Chinese Medicine and Natural Products in Improving Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 66-71. |
[12] | LI Heng-bing, YUAN Hai-ning, ZHANG Yun-jie, ZHANG Jiang-lin, GUO Zi-zhen, SUN Zhen-gao. Advances in Exosome-Based Therapy for Chronic Endometritis by Modulating the Immune Microenvironment [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 72-78. |
[13] | ZHANG Dong, WANG Zheng, LI Kai, BIAN Wen-li, GAO Zhi-hua. A Case of Severe Spontaneous Ovarian Hyperstimulation Syndrome in Non-Pregnancy [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 79-83. |
[14] | ZHANG Ye, CHEN Qiao-yun, ZHAO Jia-yi, CHEN Lu, LIU Jian-rong. Progress in the Application of Nanoparticles in the Prevention and Treatment of Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 8-12. |
[15] | DOU Miao-miao, ZHENG Jing, ZHANG Hang, YANG Bo, ZHANG Chun-jie, LIU Zhi-jie. Diagnosis and Prognosis Analysis of Accessory Cavitated Uterine Malformations: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 84-88. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||